LXRX Q2 2017 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M-40.0% YoY

Gross Profit

$12M95.5% margin

Operating Income

-$34M-281.2% margin

Net Income

-$35M-290.9% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-34.1%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$364M

Total Liabilities

$257M

Stockholders' Equity

$106M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$20M	-40.0%
Gross Profit	$12M	-$28M	+140.9%
Operating Income	-$34M	-$37M	+8.4%
Net Income	-$35M	-$38M	+8.0%